JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice.

Diagnostics (Basel) · 2024 · PMC11119658 · PMID 38786286

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Likewise, ESR showed a trend towards reduction during follow-up, although without achieving statistical significance ( p = 0.26).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

The incidence rate of serious infections (pneumonia most frequently) in patients treated with Tofacitinib was slightly higher than with Adalimumab, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.